807 related articles for article (PubMed ID: 15121641)
21. Pharmacogenetics and antipsychotics in the light of personalized pharmacotherapy.
Mihaljević-Peles A; Sagud M; Bozina N; Zivković M; Jovanović N
Psychiatr Danub; 2010 Jun; 22(2):335-7. PubMed ID: 20562776
[TBL] [Abstract][Full Text] [Related]
22. [Modern pharmacotherapy in psychiatry].
Vinar O
Psychiatr Neurol Med Psychol Beih; 1966; 4-5():155-71. PubMed ID: 4157249
[No Abstract] [Full Text] [Related]
23. Personalized medicine in psychiatry: new technologies and approaches.
Costa e Silva JA
Metabolism; 2013 Jan; 62 Suppl 1():S40-4. PubMed ID: 23018148
[TBL] [Abstract][Full Text] [Related]
24. [Psychotropic drugs].
Müller-Spahn F
Ther Umsch; 1999 Dec; 56(12):719-25. PubMed ID: 10638279
[TBL] [Abstract][Full Text] [Related]
25. The promise of psychiatric pharmacogenomics.
Hamilton SP
Biol Psychiatry; 2015 Jan; 77(1):29-35. PubMed ID: 25483343
[TBL] [Abstract][Full Text] [Related]
26. Pharmacogenetics, race, and psychiatry: prospects and challenges.
Jones DS; Perlis RH
Harv Rev Psychiatry; 2006; 14(2):92-108. PubMed ID: 16603475
[TBL] [Abstract][Full Text] [Related]
27. [Pharmacogenetics and treatment response in schizophrenia].
Moulier V; Januel D
Encephale; 2007 Dec; 33(6):954-64. PubMed ID: 18789788
[TBL] [Abstract][Full Text] [Related]
28. [Pharmacogenetics in psychiatry: state of the art].
Müller DJ; Brandl EJ; Degenhardt F; Domschke K; Grabe H; Gruber O; Hebebrand J; Maier W; Menke A; Riemenschneider M; Rietschel M; Rujescu D; Schulze TG; Tebartz van Elst L; Tüscher O; Deckert J;
Nervenarzt; 2018 Mar; 89(3):290-299. PubMed ID: 29383410
[TBL] [Abstract][Full Text] [Related]
29. The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment.
Reynolds GP; Templeman LA; Zhang ZJ
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1021-8. PubMed ID: 15953671
[TBL] [Abstract][Full Text] [Related]
30. Pharmacogenetic of response efficacy to antipsychotics in schizophrenia: pharmacodynamic aspects. Review and implications for clinical research.
Blanc O; Brousse G; Meary A; Leboyer M; Llorca PM
Fundam Clin Pharmacol; 2010 Apr; 24(2):139-60. PubMed ID: 19702693
[TBL] [Abstract][Full Text] [Related]
31. Contribution of allelic variations in transporters to the phenotype of drug response.
Kirchheiner J; Gründemann D; Schömig E
J Psychopharmacol; 2006 Jul; 20(4 Suppl):27-32. PubMed ID: 16785267
[TBL] [Abstract][Full Text] [Related]
32. Pharmacogenetics as a tool in the therapy of schizophrenia.
Wilffert B; Zaal R; Brouwers JR
Pharm World Sci; 2005 Feb; 27(1):20-30. PubMed ID: 15861931
[TBL] [Abstract][Full Text] [Related]
33. Delineating significant genome-wide associations of variants with antipsychotic and antidepressant treatment response: implications for clinical pharmacogenomics.
Koromina M; Koutsilieri S; Patrinos GP
Hum Genomics; 2020 Jan; 14(1):4. PubMed ID: 31941550
[TBL] [Abstract][Full Text] [Related]
34. CYP450 pharmacogenetic treatment strategies for antipsychotics: a review of the evidence.
Ravyn D; Ravyn V; Lowney R; Nasrallah HA
Schizophr Res; 2013 Sep; 149(1-3):1-14. PubMed ID: 23870808
[TBL] [Abstract][Full Text] [Related]
35. Oral health impacts of medications used to treat mental illness.
Cockburn N; Pradhan A; Taing MW; Kisely S; Ford PJ
J Affect Disord; 2017 Dec; 223():184-193. PubMed ID: 28759866
[TBL] [Abstract][Full Text] [Related]
36. Genetic testing for CYP2D6 and CYP2C19 suggests improved outcome for antidepressant and antipsychotic medication.
Walden LM; Brandl EJ; Tiwari AK; Cheema S; Freeman N; Braganza N; Kennedy JL; Müller DJ
Psychiatry Res; 2019 Sep; 279():111-115. PubMed ID: 29699889
[TBL] [Abstract][Full Text] [Related]
37. Individualizing antipsychotic drug therapy in schizophrenia: the promise of pharmacogenetics.
Nnadi CU; Malhotra AK
Curr Psychiatry Rep; 2007 Aug; 9(4):313-8. PubMed ID: 17880863
[TBL] [Abstract][Full Text] [Related]
38. National trends in psychotropic medication polypharmacy in office-based psychiatry.
Mojtabai R; Olfson M
Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
[TBL] [Abstract][Full Text] [Related]
39. Drugs for psychiatric disorders.
Med Lett Drugs Ther; 1989 Feb; 31(786):13-20. PubMed ID: 2563894
[No Abstract] [Full Text] [Related]
40. Pharmacogenomic implications of variants of monoaminergic-related genes in geriatric psychiatry.
Shiroma PR; Geda YE; Mrazek DA
Pharmacogenomics; 2010 Sep; 11(9):1305-30. PubMed ID: 20860469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
